Replies to post #432 on Abbvie Inc (ABBV)

[DewDiligence]

According to Vantage (one of the leading drug/biotech market-research firms), AGN’s Botox franchise has a net present value of $46.1B:

Crunching the $ABBV $AGN numbers: most valuable assets & areas of FTC overlap https://t.co/vFz4gdij9w

— Jacob Plieth (@JacobPlieth) June 25, 2019

(scan down)

If you believe that number (as I do), then ABBV is getting the remainder of AGN for a modest price.